AIDX Financials

Income Statement
MetricQ2 2026Q1 2026
Revenue
730.6K
+106.7%
353.4K
Cost of Revenue
425.8K
+46.6%
290.5K
Gross Profit
304.7K
+384.6%
62.9K
Operating Expenses
1.5M
+2.8%
1.5M
R&D
257.6K
+67.9%
153.5K
SG&A
1.3M
-4.5%
1.4M
Operating Income
-1244223
+13.8%
-1443356
EBITDA
-1237544
+13.2%
-1425425
Net Income
-1506343
+30.7%
-2174836
EPS (Basic)
$-0.26
+7.1%
$-0.28
EPS (Diluted)
$-0.26
+7.1%
$-0.28
Shares (Diluted)
10.8M
+40.9%
7.7M
20/20 Biolabs (AIDX) โ€” Financials